Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nasal vs Sublingual vs IV Fentanyl in Healthy Volunteers
NCT02470390Phase 4Completed
- Sponsor
- Assertio
- Start
- Nov 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough cancer pain (BTcP), sponsored by Assertio. Started Nov 2014; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT02470390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470390.